Loading...
•
Sep 30, 2021
STERIS Q2 2022 Earnings Report
Reported a revenue increase of 58% and adjusted EPS of $1.99.
Key Takeaways
STERIS plc announced financial results for its fiscal 2022 second quarter ended September 30, 2021. Revenue increased by 58% to $1,197 million compared to the previous year, with constant currency organic revenue growth of 12%. As reported EPS was $0.69, while adjusted EPS reached $1.99. The company is reiterating its fiscal 2022 outlook.
Second quarter revenue increased 58% as reported, with 12% constant currency organic growth.
As reported EPS was $0.69, and adjusted EPS was $1.99.
Healthcare revenue grew 58% to $744.1 million, with 10% constant currency organic growth.
Company reiterates fiscal 2022 outlook, including constant currency organic revenue growth of 10-11% and adjusted EPS of $7.60 to $7.85.
Revenue by Segment
Forward Guidance
The company is reiterating its outlook for fiscal 2022, including constant currency organic revenue growth in the range of 10-11% and adjusted earnings per share of $7.60 to $7.85.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...